CAS: 459-67-6; Hydnocarpic Acid

该化合物是一种主要来自Hydnocarpus种种籽的环球双丁基脂肪酸,其特点是独特的不饱和环状结构,具有独特的化学和生物特性,该化合物因其抗微生物和抗炎影响而在传统医学,特别是麻风病和其他皮肤病症治疗中发挥的作用而引人注目. Hydnocarpic酸也有益于有机合成和制药研究,其循环细胞是更复杂的分子的宝贵建筑块.其稳定性和再活性使其适合医学化学和脂类研究的专门应用.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:WO-2015008097-A1
      优先权日:2013-07-19
      标 题:Asymmetric synthesis of chiral compounds
      发明人:FLETCHER STEPHEN PATRICK; PORTELA MIREIA SIDERA; YOU HENGZHI; RIDEAU EMELINE
      权利人:ISIS INNOVATION; FLETCHER STEPHEN PATRICK; PORTELA MIREIA SIDERA; YOU HENGZHI; RIDEAU EMELINE
      摘要:The present invention provides processes for the production of chiral compounds in a stereoisomeric excess, the processes comprising: (i) contacting a first compound comprising an alkene or alkyne bond with a hydrometallating agent, wherein the first compound and the hydrometallating agent are contacted under conditions such that the first compound is hydrometallated by said hydrometallating agent; and (ii) contacting the hydrometallated first compound with a second compound comprising an allylic group, wherein the hydrometallated first compound and the second compound are contacted under conditions such that they undergo an asymmetric allylic alkylation reaction in which a carbon atom of the hydrometallated first compound binds to a carbon atom of said allylic group, forming a stereoisomeric excess of a compound having a chiral centre in an allylic position, said chiral centre being located at the carbon atom bound by said first compound, wherein said asymmetric allylic alkylation reaction is performed in the presence of a metal catalyst comprising a chiral ligand. In particular, the present invention provides processes for the production of a stereoisomeric excess of a compound of the formula (IA), (IB), (IA') or (IB') as defined herein.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:Chaudhury S, Hazra S, Podder GC, Poddar S, Sarkar S, Das PK, Chaudhury SN, Majumder V. New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report). Indian J Dermatol. 1987 Jul;32(3):63–7.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知